Trial intelligence / Profile preview

Intraoperative dexmedetomidine for prevention of postoperative delirium after cardiac valve surgery

ChiCTR1900022583Phase 4Recruiting

Sponsor
Fuwai Hospital
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Fuwai Hospital. Primary endpoint: Incidence of postoperative delirium. Started Mar 2019; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR1900022583.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022583.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call